With on demand medicine production at the point of care, it is now possible to tailor doses specifically to individual patients, allowing for more precise and personalised treatments with greater ease ...

We need a dedicated framework that clarifies the rules, requirements and incentives for those building personalized ...

India’s top drug regulator is stepping in to change that. The Drug Controller General of India (DCGI) is working on a nationwide overhaul of medicine packaging and labelling norms.

Tariffs of 200pc threatened by US president Donald Trump on pharmaceuticals could lead to shortages of medicine, according to Taoiseach Micheál Martin.

Nuravax Inc., a clinical-stage biopharmaceutical company developing active immunotherapies for neurodegenerative diseases, announced today that two oral presentations—the Phase 1 clinical ...

The sculpture represents a collagen molecule, the most abundant protein in the human body, and serves as “an allusion to the ...

China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, including a first-of-its-kind molecule in blood cancer. | Chinese ...

From keeping medicines safe to making them easier to use, expert partners called CDMOs are quietly transforming how drugs are packaged and delivered to patients.

From diagnosis to treatment and ongoing condition management, the patient journey is becoming an increasingly digitised one – a process which has been massively accelerated by the Covid pandemic ...

Commentary Published: September 2000 Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya. Tomas Hanke & Andrew J. McMichael Nature Medicine 6, 951 ...

Drug discovery. Read the latest in new drug development and pharmacology from leading research institutes around the world.